Soongu Kwak, Anvesha Singh, Russell J. Everett, Thomas A. Treibel, Jaehyun Lim, Sungho Won, Michelle C. Williams, Krithika Loganathan, Rong Bing, Neil Craig, Trisha Singh, Shruti Joshi, Heesun Lee, Whal Lee, Yong-Jin Kim, Calvin W. L. Chin, Miho Fukui, Tarique Al Musa, Marzia Rigolli, Lionel Tastet, Laura E. Dobson, Stephanie Wiesemann, Vanessa M. Ferreira, Gabriella Captur, Sahmin Lee, Jeanette Schulz-Menger, Erik B. Schelbert, Marie-Annick Clavel, Sung-Ji Park, Costanza Pellegrini, Martin Hadamitzky, Bernhard L. Gerber, David E. Newby, Saul G. Myerson, Phillipe Pibarot, João L. Cavalcante, Gerry P. McCann, John P. Greenwood, James C. Moon, Marc R. Dweck, Seung-Pyo Lee
{"title":"主动脉瓣狭窄患者心肌纤维化与死亡率的性别特异性关联","authors":"Soongu Kwak, Anvesha Singh, Russell J. Everett, Thomas A. Treibel, Jaehyun Lim, Sungho Won, Michelle C. Williams, Krithika Loganathan, Rong Bing, Neil Craig, Trisha Singh, Shruti Joshi, Heesun Lee, Whal Lee, Yong-Jin Kim, Calvin W. L. Chin, Miho Fukui, Tarique Al Musa, Marzia Rigolli, Lionel Tastet, Laura E. Dobson, Stephanie Wiesemann, Vanessa M. Ferreira, Gabriella Captur, Sahmin Lee, Jeanette Schulz-Menger, Erik B. Schelbert, Marie-Annick Clavel, Sung-Ji Park, Costanza Pellegrini, Martin Hadamitzky, Bernhard L. Gerber, David E. Newby, Saul G. Myerson, Phillipe Pibarot, João L. Cavalcante, Gerry P. McCann, John P. Greenwood, James C. Moon, Marc R. Dweck, Seung-Pyo Lee","doi":"10.1001/jamacardio.2024.5593","DOIUrl":null,"url":null,"abstract":"ImportanceMyocardial fibrosis in aortic stenosis (AS) may exhibit sex differences. However, its prognostic significance in women with AS remains unclear.ObjectiveTo investigate sex differences in myocardial fibrosis assessed by cardiovascular magnetic resonance (CMR) and evaluate its prognostic value in women and men with AS.Design, Setting, and ParticipantsPatients with severe AS who underwent CMR before aortic valve replacement (AVR) were prospectively enrolled from 13 international sites between March 2011 and September 2021. Myocardial fibrosis was evaluated using extracellular volume fraction (ECV%) and late gadolinium enhancement (LGE). The main analysis was conducted on patients without obstructive coronary artery disease (CAD), defined as those with no history of myocardial infarction and no concomitant coronary artery bypass grafting. Data were analyzed from December 2023 to February 2024.ExposuresSurgical or transcatheter AVR.Main Outcomes and MeasuresThe primary outcome was post–AVR all-cause mortality and the secondary outcome was cardiovascular mortality.ResultsOf 822 patients, 670 were without obstructive CAD (368 men [55%] and 302 women [45%]). Among these, women and men had a similar age (median, 72 years vs 71 years, respectively), comorbidities, and AS severity. ECV% was similar between sexes; however, women had less LGE (both infarct and noninfarct LGE). After a median follow-up of 3.7 (IQR, 2.1-4.7) years, there were 76 deaths (11.3%), including 29 adjudicated cardiovascular deaths, in patients without obstructive CAD. Increasing ECV% and LGE were associated with higher all-cause and cardiovascular mortality in both sexes. Cox analyses demonstrated that both ECV% and LGE were associated with higher all-cause mortality without significant interaction by sex (women: adjusted hazard ratio [HR], 1.08 per 1% ECV% increase; 95% CI, 1.04-1.12; <jats:italic>P</jats:italic> &amp;lt; .001; men: adjusted HR, 1.01; 95% CI, 0.96-1.06; <jats:italic>P</jats:italic> = .66; <jats:italic>P</jats:italic> for interaction by sex = .09 and women: adjusted HR, 2.49 for the presence of LGE; 95% CI, 1.07-5.80; <jats:italic>P</jats:italic> = .03; men: adjusted HR, 1.82; 95% CI, 1.00-3.32; <jats:italic>P</jats:italic> = .04; <jats:italic>P</jats:italic> for interaction by sex = .68). In the entire population (n = 822), both noninfarct and infarct-related LGE were associated with increased mortality without significant interaction by sex.Conclusions and RelevanceIn this study, patients with severe AS who underwent AVR exhibited similar ECV% between sexes, while women had lower LGE. Increased myocardial fibrosis provided important prognostic value for both sexes.","PeriodicalId":14657,"journal":{"name":"JAMA cardiology","volume":"2 1","pages":""},"PeriodicalIF":15.2000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sex-Specific Association of Myocardial Fibrosis With Mortality in Patients With Aortic Stenosis\",\"authors\":\"Soongu Kwak, Anvesha Singh, Russell J. Everett, Thomas A. Treibel, Jaehyun Lim, Sungho Won, Michelle C. Williams, Krithika Loganathan, Rong Bing, Neil Craig, Trisha Singh, Shruti Joshi, Heesun Lee, Whal Lee, Yong-Jin Kim, Calvin W. L. Chin, Miho Fukui, Tarique Al Musa, Marzia Rigolli, Lionel Tastet, Laura E. Dobson, Stephanie Wiesemann, Vanessa M. Ferreira, Gabriella Captur, Sahmin Lee, Jeanette Schulz-Menger, Erik B. Schelbert, Marie-Annick Clavel, Sung-Ji Park, Costanza Pellegrini, Martin Hadamitzky, Bernhard L. Gerber, David E. Newby, Saul G. Myerson, Phillipe Pibarot, João L. Cavalcante, Gerry P. McCann, John P. Greenwood, James C. Moon, Marc R. Dweck, Seung-Pyo Lee\",\"doi\":\"10.1001/jamacardio.2024.5593\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ImportanceMyocardial fibrosis in aortic stenosis (AS) may exhibit sex differences. However, its prognostic significance in women with AS remains unclear.ObjectiveTo investigate sex differences in myocardial fibrosis assessed by cardiovascular magnetic resonance (CMR) and evaluate its prognostic value in women and men with AS.Design, Setting, and ParticipantsPatients with severe AS who underwent CMR before aortic valve replacement (AVR) were prospectively enrolled from 13 international sites between March 2011 and September 2021. Myocardial fibrosis was evaluated using extracellular volume fraction (ECV%) and late gadolinium enhancement (LGE). The main analysis was conducted on patients without obstructive coronary artery disease (CAD), defined as those with no history of myocardial infarction and no concomitant coronary artery bypass grafting. Data were analyzed from December 2023 to February 2024.ExposuresSurgical or transcatheter AVR.Main Outcomes and MeasuresThe primary outcome was post–AVR all-cause mortality and the secondary outcome was cardiovascular mortality.ResultsOf 822 patients, 670 were without obstructive CAD (368 men [55%] and 302 women [45%]). Among these, women and men had a similar age (median, 72 years vs 71 years, respectively), comorbidities, and AS severity. ECV% was similar between sexes; however, women had less LGE (both infarct and noninfarct LGE). After a median follow-up of 3.7 (IQR, 2.1-4.7) years, there were 76 deaths (11.3%), including 29 adjudicated cardiovascular deaths, in patients without obstructive CAD. Increasing ECV% and LGE were associated with higher all-cause and cardiovascular mortality in both sexes. Cox analyses demonstrated that both ECV% and LGE were associated with higher all-cause mortality without significant interaction by sex (women: adjusted hazard ratio [HR], 1.08 per 1% ECV% increase; 95% CI, 1.04-1.12; <jats:italic>P</jats:italic> &amp;lt; .001; men: adjusted HR, 1.01; 95% CI, 0.96-1.06; <jats:italic>P</jats:italic> = .66; <jats:italic>P</jats:italic> for interaction by sex = .09 and women: adjusted HR, 2.49 for the presence of LGE; 95% CI, 1.07-5.80; <jats:italic>P</jats:italic> = .03; men: adjusted HR, 1.82; 95% CI, 1.00-3.32; <jats:italic>P</jats:italic> = .04; <jats:italic>P</jats:italic> for interaction by sex = .68). In the entire population (n = 822), both noninfarct and infarct-related LGE were associated with increased mortality without significant interaction by sex.Conclusions and RelevanceIn this study, patients with severe AS who underwent AVR exhibited similar ECV% between sexes, while women had lower LGE. Increased myocardial fibrosis provided important prognostic value for both sexes.\",\"PeriodicalId\":14657,\"journal\":{\"name\":\"JAMA cardiology\",\"volume\":\"2 1\",\"pages\":\"\"},\"PeriodicalIF\":15.2000,\"publicationDate\":\"2025-02-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAMA cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1001/jamacardio.2024.5593\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamacardio.2024.5593","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Sex-Specific Association of Myocardial Fibrosis With Mortality in Patients With Aortic Stenosis
ImportanceMyocardial fibrosis in aortic stenosis (AS) may exhibit sex differences. However, its prognostic significance in women with AS remains unclear.ObjectiveTo investigate sex differences in myocardial fibrosis assessed by cardiovascular magnetic resonance (CMR) and evaluate its prognostic value in women and men with AS.Design, Setting, and ParticipantsPatients with severe AS who underwent CMR before aortic valve replacement (AVR) were prospectively enrolled from 13 international sites between March 2011 and September 2021. Myocardial fibrosis was evaluated using extracellular volume fraction (ECV%) and late gadolinium enhancement (LGE). The main analysis was conducted on patients without obstructive coronary artery disease (CAD), defined as those with no history of myocardial infarction and no concomitant coronary artery bypass grafting. Data were analyzed from December 2023 to February 2024.ExposuresSurgical or transcatheter AVR.Main Outcomes and MeasuresThe primary outcome was post–AVR all-cause mortality and the secondary outcome was cardiovascular mortality.ResultsOf 822 patients, 670 were without obstructive CAD (368 men [55%] and 302 women [45%]). Among these, women and men had a similar age (median, 72 years vs 71 years, respectively), comorbidities, and AS severity. ECV% was similar between sexes; however, women had less LGE (both infarct and noninfarct LGE). After a median follow-up of 3.7 (IQR, 2.1-4.7) years, there were 76 deaths (11.3%), including 29 adjudicated cardiovascular deaths, in patients without obstructive CAD. Increasing ECV% and LGE were associated with higher all-cause and cardiovascular mortality in both sexes. Cox analyses demonstrated that both ECV% and LGE were associated with higher all-cause mortality without significant interaction by sex (women: adjusted hazard ratio [HR], 1.08 per 1% ECV% increase; 95% CI, 1.04-1.12; P &lt; .001; men: adjusted HR, 1.01; 95% CI, 0.96-1.06; P = .66; P for interaction by sex = .09 and women: adjusted HR, 2.49 for the presence of LGE; 95% CI, 1.07-5.80; P = .03; men: adjusted HR, 1.82; 95% CI, 1.00-3.32; P = .04; P for interaction by sex = .68). In the entire population (n = 822), both noninfarct and infarct-related LGE were associated with increased mortality without significant interaction by sex.Conclusions and RelevanceIn this study, patients with severe AS who underwent AVR exhibited similar ECV% between sexes, while women had lower LGE. Increased myocardial fibrosis provided important prognostic value for both sexes.
JAMA cardiologyMedicine-Cardiology and Cardiovascular Medicine
CiteScore
45.80
自引率
1.70%
发文量
264
期刊介绍:
JAMA Cardiology, an international peer-reviewed journal, serves as the premier publication for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. As a member of the JAMA Network, it aligns with a consortium of peer-reviewed general medical and specialty publications.
Published online weekly, every Wednesday, and in 12 print/online issues annually, JAMA Cardiology attracts over 4.3 million annual article views and downloads. Research articles become freely accessible online 12 months post-publication without any author fees. Moreover, the online version is readily accessible to institutions in developing countries through the World Health Organization's HINARI program.
Positioned at the intersection of clinical investigation, actionable clinical science, and clinical practice, JAMA Cardiology prioritizes traditional and evolving cardiovascular medicine, alongside evidence-based health policy. It places particular emphasis on health equity, especially when grounded in original science, as a top editorial priority.